Protocols here may help support those foundational processes before moving toward more targeted work
Because GLP-1 patches dont contain real GLP-1 medications and havent been studied in diabetes, they should not be considered a treatment for blood sugar control
Common examples include semaglutide (Ozempic, Wegovy, Rybelsus), liraglutide (Victoza, Saxenda), dulaglutide (Trulicity), and tirzepatide (Mounjaro), which is a dual GLP-1 and GIP receptor agonist
Because Retatrutide includes additional glucagon-driven metabolic signaling, it may be more likely to produce this shift in certain research subjects compared to Tirzepatide
GLP-1 Medications Break This Cycle: Override increased hunger signals Maintain satiety despite calorie deficit Blunt metabolic adaptation Reduce intensity of cravings Support sustained weight loss This is biological support, not just willpower
ACS Nano 4 , 36893696, doi:10.1021/nl052396o (2010)